vs
Side-by-side financial comparison of IRONWOOD PHARMACEUTICALS INC (IRWD) and MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI). Click either name above to swap in a different company.
MARAVAI LIFESCIENCES HOLDINGS, INC. is the larger business by last-quarter revenue ($49.9M vs $47.7M, roughly 1.0× IRONWOOD PHARMACEUTICALS INC). IRONWOOD PHARMACEUTICALS INC runs the higher net margin — -4.8% vs -71.6%, a 66.8% gap on every dollar of revenue. On growth, MARAVAI LIFESCIENCES HOLDINGS, INC. posted the faster year-over-year revenue change (-11.8% vs -47.3%). IRONWOOD PHARMACEUTICALS INC produced more free cash flow last quarter ($74.6M vs $-24.9M). Over the past eight quarters, MARAVAI LIFESCIENCES HOLDINGS, INC.'s revenue compounded faster (-11.9% CAGR vs -20.2%).
Ironwood Pharmaceuticals, Inc. is a publicly traded pharmaceutical company. It was originally called Microbia, Inc.
Maravai LifeSciences Holdings is a global life sciences firm developing critical reagents, diagnostic products, and tech solutions to support biopharma research, drug development, clinical diagnostics, and cell/gene therapy manufacturing. It serves biotech, pharma, research bodies and labs worldwide across three core segments.
IRWD vs MRVI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $47.7M | $49.9M |
| Net Profit | $-2.3M | $-35.7M |
| Gross Margin | — | 25.8% |
| Operating Margin | 14.3% | -117.9% |
| Net Margin | -4.8% | -71.6% |
| Revenue YoY | -47.3% | -11.8% |
| Net Profit YoY | -200.9% | -37.7% |
| EPS (diluted) | $0.01 | $-0.24 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $47.7M | $49.9M | ||
| Q3 25 | $122.1M | $41.6M | ||
| Q2 25 | $85.2M | $47.4M | ||
| Q1 25 | $41.1M | $46.9M | ||
| Q4 24 | $90.5M | $56.6M | ||
| Q3 24 | $91.6M | $69.0M | ||
| Q2 24 | $94.4M | $69.4M | ||
| Q1 24 | $74.9M | $64.2M |
| Q4 25 | $-2.3M | $-35.7M | ||
| Q3 25 | $40.1M | $-25.6M | ||
| Q2 25 | $23.6M | $-39.6M | ||
| Q1 25 | $-37.4M | $-29.9M | ||
| Q4 24 | $2.3M | $-25.9M | ||
| Q3 24 | $3.6M | $-97.1M | ||
| Q2 24 | $-860.0K | $-9.8M | ||
| Q1 24 | $-4.2M | $-12.1M |
| Q4 25 | — | 25.8% | ||
| Q3 25 | — | 13.6% | ||
| Q2 25 | — | 16.4% | ||
| Q1 25 | — | 16.5% | ||
| Q4 24 | — | 34.3% | ||
| Q3 24 | — | 46.7% | ||
| Q2 24 | — | 44.4% | ||
| Q1 24 | — | 40.3% |
| Q4 25 | 14.3% | -117.9% | ||
| Q3 25 | 61.8% | -98.6% | ||
| Q2 25 | 53.2% | -139.8% | ||
| Q1 25 | -70.7% | -104.9% | ||
| Q4 24 | 34.8% | -66.7% | ||
| Q3 24 | 28.0% | -239.9% | ||
| Q2 24 | 26.5% | -19.4% | ||
| Q1 24 | 14.7% | -29.4% |
| Q4 25 | -4.8% | -71.6% | ||
| Q3 25 | 32.8% | -61.4% | ||
| Q2 25 | 27.7% | -83.5% | ||
| Q1 25 | -90.9% | -63.9% | ||
| Q4 24 | 2.5% | -45.8% | ||
| Q3 24 | 4.0% | -140.6% | ||
| Q2 24 | -0.9% | -14.1% | ||
| Q1 24 | -5.6% | -18.8% |
| Q4 25 | $0.01 | $-0.24 | ||
| Q3 25 | $0.23 | $-0.18 | ||
| Q2 25 | $0.14 | $-0.27 | ||
| Q1 25 | $-0.23 | $-0.21 | ||
| Q4 24 | $0.03 | $-0.21 | ||
| Q3 24 | $0.02 | $-0.68 | ||
| Q2 24 | $-0.01 | $-0.07 | ||
| Q1 24 | $-0.03 | $-0.09 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $215.5M | $216.9M |
| Total DebtLower is stronger | — | $291.8M |
| Stockholders' EquityBook value | $-261.8M | $212.4M |
| Total Assets | $396.9M | $770.6M |
| Debt / EquityLower = less leverage | — | 1.37× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $215.5M | $216.9M | ||
| Q3 25 | $140.4M | $243.6M | ||
| Q2 25 | $92.9M | $269.9M | ||
| Q1 25 | $108.5M | $285.1M | ||
| Q4 24 | $88.6M | $322.4M | ||
| Q3 24 | $88.2M | $578.2M | ||
| Q2 24 | $105.5M | $573.2M | ||
| Q1 24 | $121.5M | $561.7M |
| Q4 25 | — | $291.8M | ||
| Q3 25 | $199.5M | $292.8M | ||
| Q2 25 | $199.3M | $293.9M | ||
| Q1 25 | $199.2M | $294.9M | ||
| Q4 24 | $199.0M | $295.9M | ||
| Q3 24 | $198.8M | $521.7M | ||
| Q2 24 | $198.6M | $522.5M | ||
| Q1 24 | $398.3M | $523.3M |
| Q4 25 | $-261.8M | $212.4M | ||
| Q3 25 | $-264.2M | $245.4M | ||
| Q2 25 | $-308.2M | $265.9M | ||
| Q1 25 | $-334.1M | $300.6M | ||
| Q4 24 | $-301.3M | $325.3M | ||
| Q3 24 | $-311.3M | $344.9M | ||
| Q2 24 | $-321.7M | $434.7M | ||
| Q1 24 | $-330.5M | $410.7M |
| Q4 25 | $396.9M | $770.6M | ||
| Q3 25 | $396.1M | $849.2M | ||
| Q2 25 | $342.9M | $897.0M | ||
| Q1 25 | $327.2M | $959.8M | ||
| Q4 24 | $350.9M | $1.0B | ||
| Q3 24 | $389.5M | $1.3B | ||
| Q2 24 | $395.6M | $1.4B | ||
| Q1 24 | $438.8M | $1.4B |
| Q4 25 | — | 1.37× | ||
| Q3 25 | — | 1.19× | ||
| Q2 25 | — | 1.11× | ||
| Q1 25 | — | 0.98× | ||
| Q4 24 | — | 0.91× | ||
| Q3 24 | — | 1.51× | ||
| Q2 24 | — | 1.20× | ||
| Q1 24 | — | 1.27× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $74.6M | $-22.8M |
| Free Cash FlowOCF − Capex | $74.6M | $-24.9M |
| FCF MarginFCF / Revenue | 156.3% | -49.9% |
| Capex IntensityCapex / Revenue | 0.0% | 4.2% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $127.0M | $-70.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $74.6M | $-22.8M | ||
| Q3 25 | $47.6M | $-15.2M | ||
| Q2 25 | $-15.1M | $-10.3M | ||
| Q1 25 | $20.0M | $-9.4M | ||
| Q4 24 | $15.2M | $-14.6M | ||
| Q3 24 | $9.9M | $13.1M | ||
| Q2 24 | $33.5M | $17.4M | ||
| Q1 24 | $45.0M | $-8.5M |
| Q4 25 | $74.6M | $-24.9M | ||
| Q3 25 | $47.6M | $-18.1M | ||
| Q2 25 | $-15.1M | $-13.1M | ||
| Q1 25 | $19.9M | $-14.6M | ||
| Q4 24 | — | $-20.5M | ||
| Q3 24 | $9.9M | $4.5M | ||
| Q2 24 | $33.4M | $7.9M | ||
| Q1 24 | $44.9M | $-14.1M |
| Q4 25 | 156.3% | -49.9% | ||
| Q3 25 | 39.0% | -43.4% | ||
| Q2 25 | -17.7% | -27.7% | ||
| Q1 25 | 48.4% | -31.2% | ||
| Q4 24 | — | -36.2% | ||
| Q3 24 | 10.8% | 6.6% | ||
| Q2 24 | 35.4% | 11.4% | ||
| Q1 24 | 60.0% | -22.0% |
| Q4 25 | 0.0% | 4.2% | ||
| Q3 25 | 0.0% | 7.0% | ||
| Q2 25 | 0.0% | 6.1% | ||
| Q1 25 | 0.1% | 11.2% | ||
| Q4 24 | 0.0% | 10.3% | ||
| Q3 24 | 0.0% | 12.4% | ||
| Q2 24 | 0.1% | 13.8% | ||
| Q1 24 | 0.1% | 8.8% |
| Q4 25 | — | — | ||
| Q3 25 | 1.19× | — | ||
| Q2 25 | -0.64× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 6.74× | — | ||
| Q3 24 | 2.71× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
IRWD
Segment breakdown not available.
MRVI
| Cygnus Segment | $27.2M | 54% |
| Other | $18.4M | 37% |
| Shipping And Handling | $4.3M | 9% |
